ISU grad student selected to meet Nobel laureates
Iowa State graduate student Jonathan Mullin will talk chemistry with 23 Nobel laureates and students from around the world in Lindau, Germany, June 25-30.
ISU at Des Moines Arts Festival June 23-25
Iowa State's display at the Des Moines Arts Festival will feature a pavilion that showcases the university's arts and humanities and emphasizes the connections among them. The event runs Friday through Sunday in downtown Des Moines.
Plant scientists tweak biopharm corn research
A biopharmaceutical corn created at Iowa State University is getting a makeover. Researchers are developing the corn into a variety that keeps the therapeutic protein, but eliminates the pollen.
LeSar to lead ISU's materials science and engineering department
Richard Alan LeSar, a technical staff member in the Theoretical Division of Los Alamos National Laboratory in Los Alamos, N.M., will assume leadership of Iowa State's department of materials science and engineering on Aug. 1.
Food companies to test new soybean oil from ISU
An Iowa State soybean breeding team developed a new soy oil that could confer the trans fat-free benefits of unhydrogenated soy oil to more food products than ever before.
Why do some cheat?
Research indicates people rationalize cheating by distancing themselves from unethical actions.
ISU psychologists find mother's self-fulfilling prophecy influences child's alcohol use
Effects of self-fulfilling beliefs can add up over time and may lead to inequalities between individuals, according to a study on mothers' beliefs about their children's alcohol use by Iowa State University researchers.
Vet med faculty co-develop new vaccine
Two Iowa State veterinary medicine faculty were instrumental in the six-year development of the first, fully licensed vaccine for one of the worlds' most significant pig viruses. First identified in the early 1990s, the porcine circovirus type 2 causes respiratory diseases that can kill up to 30 percent of herds infected. Dr. Patrick Halbur and Dr. Tanja Opriessnig partnered with scientists at Virginia Tech to develop and test the new vaccine, which is being manufactured by Fort Dodge Animal Health, Overland Park, Kansas.